HK1006020A1 - Method of improving sleep - Google Patents

Method of improving sleep

Info

Publication number
HK1006020A1
HK1006020A1 HK98105168A HK98105168A HK1006020A1 HK 1006020 A1 HK1006020 A1 HK 1006020A1 HK 98105168 A HK98105168 A HK 98105168A HK 98105168 A HK98105168 A HK 98105168A HK 1006020 A1 HK1006020 A1 HK 1006020A1
Authority
HK
Hong Kong
Prior art keywords
6alkyl
aminocarbonyl
optionally substituted
hydroxyc1
chem
Prior art date
Application number
HK98105168A
Other languages
English (en)
Inventor
Georges Henri Paul Van Daele
Freddy Francois Vlaeminck
Marc Gustaaf Celine Verdonck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1006020A1 publication Critical patent/HK1006020A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Anesthesiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Photolithography (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
HK98105168A 1987-04-01 1998-06-11 Method of improving sleep HK1006020A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3412987A 1987-04-01 1987-04-01

Publications (1)

Publication Number Publication Date
HK1006020A1 true HK1006020A1 (en) 1999-02-05

Family

ID=21874492

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105168A HK1006020A1 (en) 1987-04-01 1998-06-11 Method of improving sleep

Country Status (21)

Country Link
EP (2) EP0285219B1 (xx)
JP (1) JP2574377B2 (xx)
KR (1) KR960016539B1 (xx)
AT (2) ATE207474T1 (xx)
AU (1) AU609790B2 (xx)
CA (1) CA1315790C (xx)
DE (2) DE3856501T2 (xx)
DK (1) DK174878B1 (xx)
ES (2) ES2091183T3 (xx)
FI (1) FI97617C (xx)
GR (1) GR3020983T3 (xx)
HK (1) HK1006020A1 (xx)
HU (2) HUT57740A (xx)
IE (1) IE81057B1 (xx)
IL (1) IL85919A (xx)
NO (1) NO178660C (xx)
NZ (1) NZ223847A (xx)
PH (1) PH25507A (xx)
PT (1) PT87118B (xx)
RU (1) RU2014328C1 (xx)
ZA (1) ZA882352B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2044143C (en) * 1989-11-22 2002-11-19 Herman Van Belle Method of preventing or limiting reperfusion damage
US5840896A (en) * 1989-11-22 1998-11-24 Janssen Pharmaceutica, N.V. Method of preventing or limiting reperfusion damage
JP2660086B2 (ja) * 1990-07-03 1997-10-08 明治製菓株式会社 脳及び心機能障害改善剤
US5276035A (en) * 1990-07-26 1994-01-04 Novo Nordisk A/S 1,4-disubstituted piperazines
EP0582164B1 (en) * 1992-07-31 1998-12-23 Bristol-Myers Squibb Company Adenosine re-uptake inhibiting derivatives of diphenyl oxazoles, thiazoles and imidazoles
SE9202266D0 (sv) * 1992-07-31 1992-07-31 Kabi Pharmacia Ab Novel piperazine carboxamides
DK0756593T3 (da) * 1994-04-20 2000-11-13 Lonza Ag Fremgangsmåde til fremstilling af 2-piperazincarboxylsyrederivater
US5866574A (en) * 1997-04-10 1999-02-02 Kyowa Hakko Kogyo Co., Ltd. Pancreatitis remedy
DE69814089T2 (de) * 1997-06-16 2004-02-19 Janssen Pharmaceutica N.V. Verwendung von einem draflazin analog zur schmerzbehandlung
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
WO2006074025A1 (en) 2004-12-30 2006-07-13 Janssen Pharmaceutica N.V. Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase
UA108233C2 (uk) 2010-05-03 2015-04-10 Модулятори активності гідролази амідів жирних кислот
CN110511220B (zh) * 2018-05-22 2022-04-01 上海挚盟医药科技有限公司 作为钾通道调节剂的对二氨基苯衍生物、其制备方法及其在医药上的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1795375A1 (de) * 1968-09-21 1972-01-05 Boehringer Mannheim Gmbh Basische AEther und Verfahren zur Herstellung derselben
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia

Also Published As

Publication number Publication date
DK179788D0 (da) 1988-03-30
DE3856501T2 (de) 2004-04-29
PT87118A (pt) 1988-04-01
DK179788A (da) 1988-10-02
HU211129A9 (en) 1995-10-30
EP0285219A2 (en) 1988-10-05
NO178660B (no) 1996-01-29
FI881525A (fi) 1988-10-02
IL85919A0 (en) 1988-09-30
FI97617C (fi) 1997-01-27
JP2574377B2 (ja) 1997-01-22
EP0727421A1 (en) 1996-08-21
KR880012566A (ko) 1988-11-28
ZA882352B (en) 1989-12-27
ATE142627T1 (de) 1996-09-15
DE3856501D1 (de) 2001-11-29
NO881407D0 (no) 1988-03-29
AU609790B2 (en) 1991-05-09
DK174878B1 (da) 2004-01-12
RU2014328C1 (ru) 1994-06-15
CA1315790C (en) 1993-04-06
DE3855520T2 (de) 1997-02-06
EP0285219B1 (en) 1996-09-11
NZ223847A (en) 1989-12-21
NO881407L (no) 1988-10-03
EP0285219A3 (en) 1991-07-03
NO178660C (no) 1996-05-08
KR960016539B1 (ko) 1996-12-14
EP0727421B1 (en) 2001-10-24
GR3020983T3 (en) 1996-12-31
DE3855520D1 (de) 1996-10-17
ES2091183T3 (es) 1996-11-01
FI97617B (fi) 1996-10-15
HUT57740A (en) 1991-12-30
ES2167510T3 (es) 2002-05-16
JPS63290869A (ja) 1988-11-28
FI881525A0 (fi) 1988-03-31
IL85919A (en) 1992-12-01
PH25507A (en) 1991-07-24
IE81057B1 (en) 1999-12-29
IE880989L (en) 1988-10-01
AU1384788A (en) 1988-10-06
ATE207474T1 (de) 2001-11-15
PT87118B (pt) 1992-07-31

Similar Documents

Publication Publication Date Title
HUT70426A (en) Pyrazolo-pyrimidine derivatives, process for preparing them and pharmaceutical compositions containing them as active agents
DE3176010D1 (en) Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids, salts thereof, pharmaceutical compositions containing the derivatives or salts, and the production of the same
HUT58322A (en) Process for producing new n-(3-hydroxy-4-piperidinyl)-dihydro-benzofurane-, -dihydro-2h-penzopyrane- and -dihydro-benzodioxine-carboxamide derivatives and pharmaceutical compositions containing them
EP0151824A3 (en) N-(4-piperidinyl) bicyclic condesed 2-imidazolamine derivatives
HUT48617A (en) Process for producing new pyridazine-amine derivatives and pharmaceutical compositions comprising same
HUT43051A (en) Process for preparing pyridine-carboxylic acid derivatives and pharmaceutical compositions containing thereof as active ingredients
ZA882352B (en) Method of improving sleep
HUT40101A (en) Process for producing quinolin-carboxylic acid derivatives and pharmaceutical compositions containing them as active agents
IE890177L (en) Piperidinyl derivatives
IL86080A (en) Substituted alkoxy-2-alkyl-indan and 1,2,3,4-tetrahydro-naphthol,process for the preparation thereof and pharmaceutical compositions comprising the same
HUT52099A (en) Process for producing antiviral tetrahydroimidazo/1,4/benzodiazepin-2-one derivatives and pharmaceutical compositions comprising such compounds as active ingredient
NZ233526A (en) Pyridazine derivatives and their pharmaceutical compositions
IL87107A0 (en) Naphthothiazepine derivatives,their preparation and pharmaceutical compositions containing them
FI894125A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisen 3-piperidinyyli-indatsolin valmistamiseksi
EP0323604A3 (en) A venous extensibility improving and cardiac hypertrophy suppressant agent containing a dihydropyridine compound
JPS5673047A (en) Decaprenylamine derivative
DK158513C (da) N-(substitueret phenyl)-n'-pyridinylurinstoffer, fremgangsmaade til fremstilling deraf samt farmaceutiske praeparater indeholdende disse
JPS643181A (en) Pyridonecarboxylic acid derivative

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)